US Biologic® to Present Development of a Chewable Flu Vaccine: Offers New Tool to Increase Vaccine Equity, Avoid Needles, and Reduce Pandemics ...Middle East

MEMPHIS, Tenn., Nov. 7, 2022 /PRNewswire/ -- US Biologic, a leading global entity in the development, commercialization, and distribution of orally delivered vaccines, announced today that Dr. Jolieke G. van Oosterwijk, US Biologic Chief Scientific Officer, will present key findings on a...

Hence then, the article about us biologic to present development of a chewable flu vaccine offers new tool to increase vaccine equity avoid needles and reduce pandemics was published today ( Monday 07/11/2022 - 08:17 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( US Biologic® to Present Development of a Chewable Flu Vaccine: Offers New Tool to Increase Vaccine Equity, Avoid Needles, and Reduce Pandemics )

Also on site :

• Russian hockey legend Ovechkin refuses to wear LGBT tape
• After the Fire, Hope Valley Faces Its First Reckoning in 'When Calls the Heart' Season 13 Episode 3
• Merz criticizes Germans for getting sick too often